Manufacturer
DUOPHARMA (M) SDN. BHD.
Contents
Dimenhydrinate
Indication
Treatment and prophylaxis of motion sickness, Nausea and vertigo caused by Meniere's disease
Instruction
Adult: 50-100 mg 4 hrly via IM or slow IV inj over 2 min.
Child: 1.25 mg/kg 4 times daily via IM. Max: 300 mg daily.
Drug interaction
Increased sedation when used w/ other CNS depressants. May mask the early symptoms of ototoxicity when used w/ aminoglycosides or other ototoxic drugs. May potentiate the effects of other drugs w/ anticholinergic activity (e.g. TCAs).
Malaysia
